What pregnancy, fertility, and contraception questions should be discussed before tirzepatide?

Before starting tirzepatide, discuss stopping it 2+ months before a planned pregnancy, its impact on oral contraceptives, and potential fertility changes.

Pregnancy Planning and Tirzepatide Discontinuation

Tirzepatide (the active ingredient in Mounjaro and Zepbound) is not recommended during pregnancy. There is limited data on its use in pregnant humans, but animal reproduction studies showed potential risks, including fetal malformations and reductions in fetal growth at certain exposure levels.

Based on the medication's properties, the U.S. FDA label recommends that tirzepatide be discontinued at least 2 months before a planned pregnancy. This "washout period" gives the drug enough time to clear from the body before conception.

A pregnancy exposure registry monitors pregnancy outcomes in individuals who take tirzepatide while pregnant. The purpose of the registry is to collect information to help understand the safety of the medication during pregnancy. Participation is voluntary.

It is critical to inform your physician immediately if you become pregnant or are planning to become pregnant while participating in a physician-supervised weight management program.

Impact on Oral Contraceptive Effectiveness

Tirzepatide and other GLP-1 receptor agonists work by delaying gastric emptying, which slows down the movement of food and other substances from the stomach into the intestines. This action is a key part of how it helps with blood sugar control and weight loss.

This delay can also slow the absorption of oral medications, including hormonal birth control pills. Reduced or delayed absorption could potentially decrease the effectiveness of oral contraceptives, thereby increasing the risk of an unintended pregnancy.

Because of this drug interaction, the FDA advises patients taking oral hormonal contraceptives to either switch to a non-oral contraceptive method (such as an IUD, patch, vaginal ring, or injection) or to add a barrier method (like condoms) to their routine.

This precaution is specifically recommended for 4 weeks after starting tirzepatide and for 4 weeks following each dose escalation. These are the periods when the effect on gastric emptying is most significant as your body adjusts to the new dose.

Fertility Considerations and Unexpected Pregnancy

Significant weight loss can lead to improvements in metabolic health. For women with obesity-related hormonal imbalances, such as those with polycystic ovary syndrome (PCOS), this can lead to the return of regular ovulation and menstrual cycles.

While improved fertility is a positive health outcome, it can result in an unplanned pregnancy if the individual is not using a reliable form of contraception. This phenomenon is a known consideration in medical weight management.

The combination of potentially increased fertility (due to weight loss) and potentially decreased oral contraceptive efficacy (due to delayed gastric emptying) creates a critical period of risk. A robust and reliable contraception plan is essential for anyone of reproductive potential taking tirzepatide who is not actively seeking to become pregnant.

Checklist: Key Topics for Your Physician Discussion

**Pregnancy Status & Plans:** Discuss your current pregnancy status and any intentions to conceive. This will determine if tirzepatide is appropriate and help establish a timeline for stopping the medication at least 2 months prior to attempting conception.

**Current Contraception Method:** Be specific about your current birth control method. If you rely on an oral pill, your provider will likely recommend adding a barrier method or switching to a non-oral option during initiation and dose increases.

**Menstrual & Fertility History:** Share your menstrual history, especially any past irregularities or diagnosed conditions like PCOS. Understanding your baseline fertility helps you and your provider anticipate changes as you lose weight, reinforcing the need for effective birth control.

**Protocol for Accidental Pregnancy:** Establish a clear plan for what to do if you discover you are pregnant. The standard recommendation is to stop the medication immediately and contact your provider. You can find more safety information for GLP-1s in the GOAL.MD Answers library.

Bottom Line

Openly discussing your family planning and contraception with your provider is a critical safety step before starting tirzepatide. The medication is not recommended during pregnancy or breastfeeding due to insufficient human safety data and findings from animal studies.

Key topics for discussion include planning for a 2-month washout period before trying to conceive, addressing the reduced effectiveness of oral contraceptives, and being aware that weight loss may restore fertility.

Under a physician-supervised program using medication from licensed U.S. pharmacies, a reliable contraception strategy is essential for sexually active individuals of reproductive potential who are taking tirzepatide but not planning a pregnancy.

This information is for educational purposes only and does not constitute medical advice.

Generated from GOAL.MD's physician-reviewed source library. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.